The recently published report by Boston Consulting Group, prepared together with World Economic Forum, Wellcome Trust, and the Novo Nordisk Foundation, focuses on the…
FasterCures and Financial Innovations Labs® have joint forces on a project to identify new financing models to revive the R&D pipeline for new antibiotics against…
ArrePath announced that it has raised $20 million in seed financing to advance its proprietary, machine learning (ML)-based platform for the discovery of new…
BIO has published a new report that takes a closer look at the recent investment into antibacterial innovation and the current clinical pipeline, both…
BWC0977, Bugwork’s candidate for a novel broad spectrum anti-bacterial agent, will be further developed with financial support by Global Investor Syndicate led by Lightrock…
The AMR Action Fund has moved into its new European office in Basel. The venture fund is the largest public-private partnership for the development…
The AMR Action Fund has named several experts as members of its Scientific Advisory Board (SAB). The recently established board holds in total nine…
Mutabilis, based in Romainville, France, announced that it has closed the deal on a Research Collaboration and License Agreement with Roche on its 2G-Dabocins…
BEAM Alliance has released a new position paper outlining five pillars for an effective AMR pull incentive mechanism in Europe from the SME perspective.…